{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:51:36Z","timestamp":1768899096728,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Resistin, secreted from adipocytes, causes insulin resistance in mice. The relationship between resistin and coronary artery disease is highly controversial, and the information regarding resistin and ischemic stroke is limited. In the present study, the association between serum resistin concentration and cardiovascular disease (CVD) was investigated in a general Japanese population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A total of 3,201 community-dwelling individuals aged 40 years or older (1,382 men and 1,819 women) were divided into quintiles of serum resistin, and the association between resistin and CVD was examined cross-sectionally. The combined effect of either diabetes or hypertension and high serum resistin was also assessed. Serum resistin was measured using ELISA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Compared to those without CVD, age- and sex-adjusted mean serum resistin concentrations were greater in subjects with CVD (p = 0.002) or ischemic stroke (p &lt; 0.001), especially in those with lacunar and atherothrombotic infarction, but not elevated in subjects with hemorrhagic stroke or coronary heart disease. When analyzed by quintile of serum resistin concentration, the age- and sex-adjusted odds ratio (OR) for having CVD and ischemic stroke increased with quintile of serum resistin (p for trends, 0.02 for CVD, &lt; 0.001 for ischemic stroke), while such associations were not observed for hemorrhagic stroke or coronary heart disease. Compared to the first quintile, the age- and sex-adjusted OR of ischemic stroke was greater in the third (OR = 3.54; 95% confidence interval [CI], 1.17-10.67; p = 0.02), fourth (OR = 4.48; 95% CI, 1.53-13.09; p = 0.006), and fifth quintiles (OR = 4.70; 95% CI, 1.62-13.61; p = 0.004). These associations remained substantially unchanged even after adjustment for other confounding factors including high-sensitivity C-reactive protein. In the stratified analysis, the combination of high serum resistin and either diabetes or hypertension markedly increased the risk of ischemic stroke.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Elevated serum resistin concentration appears to be an independent risk factor for ischemic stroke, especially lacunar and atherothrombotic infarction in the general Japanese population. The combination of high resistin and the presence of either diabetes or hypertension increased the risk of ischemic stroke.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2840-8-60","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:07:25Z","timestamp":1258589245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study"],"prefix":"10.1186","volume":"8","author":[{"given":"Haruhiko","family":"Osawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasufumi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideichi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumihiro","family":"Tanizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,18]]},"reference":[{"issue":"4","key":"214_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2796.2004.01306.x","volume":"255","author":"CM Steppan","year":"2004","unstructured":"Steppan CM, Lazar MA: The current biology of resistin. J Intern Med. 2004, 255 (4): 439-447. 10.1111\/j.1365-2796.2004.01306.x.","journal-title":"J Intern Med"},{"issue":"14","key":"214_CR2","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1074\/jbc.C100028200","volume":"276","author":"KH Kim","year":"2001","unstructured":"Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001, 276 (14): 11252-11256. 10.1074\/jbc.C100028200.","journal-title":"J Biol Chem"},{"issue":"7","key":"214_CR3","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.2337\/diabetes.53.7.1671","volume":"53","author":"MW Rajala","year":"2004","unstructured":"Rajala MW, Qi Y, Patel HR, Takahashi N, Banerjee R, Pajvani UB, Sinha MK, Gingerich RL, Scherer PE, Ahima RS: Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004, 53 (7): 1671-1679. 10.2337\/diabetes.53.7.1671.","journal-title":"Diabetes"},{"issue":"6818","key":"214_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409 (6818): 307-312. 10.1038\/35053000.","journal-title":"Nature"},{"issue":"2","key":"214_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003, 300 (2): 472-476. 10.1016\/S0006-291X(02)02841-3.","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"214_CR6","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1161\/01.CIR.0000147825.97879.E7","volume":"110","author":"P Calabro","year":"2004","unstructured":"Calabro P, Samudio I, Willerson JT, Yeh ET: Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1\/2 and phosphatidylinositol 3-kinase pathways. Circulation. 2004, 110 (21): 3335-3340. 10.1161\/01.CIR.0000147825.97879.E7.","journal-title":"Circulation"},{"issue":"6","key":"214_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.CIR.0000084503.91330.49","volume":"108","author":"S Verma","year":"2003","unstructured":"Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003, 108 (6): 736-740. 10.1161\/01.CIR.0000084503.91330.49.","journal-title":"Circulation"},{"issue":"11","key":"214_CR8","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.ijo.0803037","volume":"29","author":"S Bo","year":"2005","unstructured":"Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF: Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond). 2005, 29 (11): 1315-1320. 10.1038\/sj.ijo.0803037.","journal-title":"Int J Obes (Lond)"},{"issue":"7","key":"214_CR9","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1210\/jc.2005-2115","volume":"91","author":"A Kunnari","year":"2006","unstructured":"Kunnari A, Ukkola O, Paivansalo M, Kesaniemi YA: High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab. 2006, 91 (7): 2755-2760. 10.1210\/jc.2005-2115.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"214_CR10","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","volume":"27","author":"GK Shetty","year":"2004","unstructured":"Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004, 27 (10): 2450-2457. 10.2337\/diacare.27.10.2450.","journal-title":"Diabetes Care"},{"issue":"1","key":"214_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.atherosclerosis.2006.11.017","volume":"196","author":"S Lim","year":"2008","unstructured":"Lim S, Koo BK, Cho SW, Kihara S, Funahashi T, Cho YM, Kim SY, Lee HK, Shimomura I, Park KS: Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean atherosclerosis study (KAS): a 42-month prospective study. Atherosclerosis. 2008, 196 (1): 398-404. 10.1016\/j.atherosclerosis.2006.11.017.","journal-title":"Atherosclerosis"},{"issue":"3","key":"214_CR12","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2265.2007.02743.x","volume":"66","author":"S Pilz","year":"2007","unstructured":"Pilz S, Weihrauch G, Seelhorst U, Wellnitz B, Winkelmann BR, Boehm BO, Marz W: Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxf). 2007, 66 (3): 380-386. 10.1111\/j.1365-2265.2007.02743.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"214_CR13","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ: Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005, 111 (7): 932-939. 10.1161\/01.CIR.0000155620.10387.43.","journal-title":"Circulation"},{"issue":"7","key":"214_CR14","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2007-2735","volume":"93","author":"C Weikert","year":"2008","unstructured":"Weikert C, Westphal S, Berger K, Dierkes J, Mohlig M, Spranger J, Rimm EB, Willich SN, Boeing H, Pischon T: Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab. 2008, 93 (7): 2647-2653. 10.1210\/jc.2007-2735.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"214_CR15","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1210\/jc.2007-2819","volume":"93","author":"Y Doi","year":"2008","unstructured":"Doi Y, Kubo M, Yonemoto K, Ninomiya T, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y: Fasting plasma glucose cutoff for diagnosis of diabetes in a Japanese population. J Clin Endocrinol Metab. 2008, 93 (9): 3425-3429. 10.1210\/jc.2007-2819.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"214_CR16","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1212\/01.wnl.0000216132.95207.b4","volume":"66","author":"M Kubo","year":"2006","unstructured":"Kubo M, Kiyohara Y, Ninomiya T, Tanizaki Y, Yonemoto K, Doi Y, Hata J, Oishi Y, Shikata K, Iida M: Decreasing incidence of lacunar vs other types of cerebral infarction in a Japanese population. Neurology. 2006, 66 (10): 1539-1544. 10.1212\/01.wnl.0000216132.95207.b4.","journal-title":"Neurology"},{"issue":"10","key":"214_CR17","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1161\/01.STR.0000090348.52943.A2","volume":"34","author":"M Kubo","year":"2003","unstructured":"Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M: Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama Study. Stroke. 2003, 34 (10): 2349-2354. 10.1161\/01.STR.0000090348.52943.A2.","journal-title":"Stroke"},{"issue":"4","key":"214_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/01.STR.21.4.637","volume":"21","author":"A report by a committee established by the Director of the National Institute of Neurological Disorders and Stroke NIoH, Bethesda, Maryland","year":"1990","unstructured":"A report by a committee established by the Director of the National Institute of Neurological Disorders and Stroke NIoH, Bethesda, Maryland: Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990, 21 (4): 637-676.","journal-title":"Stroke"},{"issue":"1","key":"214_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993, 24 (1): 35-41.","journal-title":"Stroke"},{"key":"214_CR20","doi-asserted-by":"crossref","unstructured":"Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol. 1986, 43 (1): 71-84.","DOI":"10.1001\/archneur.1986.00520010065026"},{"issue":"11","key":"214_CR21","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1161\/01.STR.31.11.2616","volume":"31","author":"Y Tanizaki","year":"2000","unstructured":"Tanizaki Y, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Shinohara N, Arima H, Tanaka K, Ibayashi S, Fujishima M: Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke. 2000, 31 (11): 2616-2622.","journal-title":"Stroke"},{"issue":"2","key":"214_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.bbrc.2005.07.122","volume":"335","author":"H Osawa","year":"2005","unstructured":"Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T, Tanabe F, Shimizu I, Kato K, Nishida W: Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun. 2005, 335 (2): 596-602.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"214_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/dc06-1936","volume":"30","author":"H Osawa","year":"2007","unstructured":"Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K: Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care. 2007, 30 (6): 1501-1506. 10.2337\/dc06-1936.","journal-title":"Diabetes Care"},{"issue":"4","key":"214_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1086\/424761","volume":"75","author":"H Osawa","year":"2004","unstructured":"Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W: The G\/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1\/3. Am J Hum Genet. 2004, 75 (4): 678-686. 10.1086\/424761.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"214_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/WNL.32.8.871","volume":"32","author":"CM Fisher","year":"1982","unstructured":"Fisher CM: Lacunar strokes and infarcts: a review. Neurology. 1982, 32 (8): 871-876.","journal-title":"Neurology"},{"issue":"2","key":"214_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diabres.2008.10.021","volume":"84","author":"T Tsukahara","year":"2009","unstructured":"Tsukahara T, Nakashima E, Watarai A, Hamada Y, Naruse K, Kamiya H, Nakamura N, Kato N, Hamajima N, Sekido Y: Polymorphism in resistin promoter region at -420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients. Diabetes Res Clin Pract. 2009, 84 (2): 179-186. 10.1016\/j.diabres.2008.10.021.","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"214_CR27","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001, 32 (12): 2735-2740. 10.1161\/hs1201.100209.","journal-title":"Stroke"},{"issue":"10","key":"214_CR28","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1161\/01.STR.31.10.2385","volume":"31","author":"G Saposnik","year":"2000","unstructured":"Saposnik G, Caplan LR, Gonzalez LA, Baird A, Dashe J, Luraschi A, Llinas R, Lepera S, Linfante I, Chaves C: Differences in stroke subtypes among natives and caucasians in Boston and Buenos Aires. Stroke. 2000, 31 (10): 2385-2389.","journal-title":"Stroke"},{"issue":"9","key":"214_CR29","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174 (9): 5789-5795.","journal-title":"J Immunol"},{"issue":"4","key":"214_CR30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.metabol.2007.11.010","volume":"57","author":"CL Aquilante","year":"2008","unstructured":"Aquilante CL, Kosmiski LA, Knutsen SD, Zineh I: Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism. 2008, 57 (4): 494-501. 10.1016\/j.metabol.2007.11.010.","journal-title":"Metabolism"},{"issue":"5","key":"214_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1464-5491.2005.01480.x","volume":"22","author":"A Kunnari","year":"2005","unstructured":"Kunnari A, Ukkola O, Kesaniemi YA: Resistin polymorphisms are associated with cerebrovascular disease in Finnish Type 2 diabetic patients. Diabet Med. 2005, 22 (5): 583-589. 10.1111\/j.1464-5491.2005.01480.x.","journal-title":"Diabet Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-8-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:44:17Z","timestamp":1630475057000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-8-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["214"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-8-60","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,18]]},"assertion":[{"value":"29 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}